Lin Celia 4
4 · Vera Therapeutics, Inc. · Filed Feb 18, 2022
Insider Transaction Report
Form 4
Lin Celia
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-16+52,412→ 52,412 totalExercise: $20.94Exp: 2032-02-15→ Class A Common Stock (52,412 underlying)
Footnotes (1)
- [F1]1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 16, 2022, subject to continuous service of the Reporting Person on each vesting date.